Ghost Tree Capital, LLC Travere Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$7.64 - $17.25 $1.15 Million - $2.59 Million
150,000 New
150,000 $1.34 Million
Q1 2021

May 14, 2021
SELL
$23.37 - $31.77 $11.1 Million - $15.1 Million
-475,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$19.17 - $27.87 $9.11 Million - $13.2 Million
475,000 New
475,000 $12.9 Million

Others Institutions Holding TVTX

# of Institutions
196
Shares Held
84.9M
Call Options Held
776K
Put Options Held
900K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.3B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email